Company
BiomeSense
Leveraging the power of big data & AI to unlock microbiome precision medicine.
Also known as biomesense.com
- Status
- Operatingas of 2026-09-22
- Business model
- B2B
- Customers
- leading scientists, institutions, and companies conducting clinical research into the gut microbiome
- Legal name
- BiomeSense, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
To accelerate our path to that future, we developed the first AI-enabled technology platform for reliable, longitudinal, and low-cost generation & analysis of microbiome data. Our mission is to partner with leading scientists and companies across the field, providing them with continuous, comprehensive microbiome data and AI-enabled bioinformatics to unlock the microbiome's full personalized medicine potential.
Funding snapshot
- Total raised
- $15.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Seed, $7M2025-10-20
Funding rounds
- Seed
- $7M2025-10-20, Company stated
- Round, 2025
- $7.1M2025-07-18, SEC form D sold, 27 investors
- Round, 2023
- $6.2M2023-02-14, SEC form D sold, 33 investors
- Round, 2019
- $2.4M2019-09-17, SEC form D sold, 5 investors
Products
- Hardware
- GutLab
- Other
- MetaBiome
Loading relationship preview